Theravance Biopharma, Inc. (TBPH) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Theravance Biopharma, Inc.
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an…
Source: Yahoo Finance
Sector & Industry
Theravance Biopharma, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Theravance Biopharma, Inc. at a Glance
| Company | Theravance Biopharma, Inc. |
| Ticker | TBPH |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $17.08 |
| Market cap | $886.77M |
| P/E ratio (trailing) | 16.42 |
| EPS (trailing) | $1.04 |
| 52-week high | $21.03 |
| 52-week low | $13.08 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.24 |
| Return on equity (ROE) | 20.91% |
| Debt-to-equity | 13.31% |
| Average volume | 642,615 |
| Shares outstanding | 51.92M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 90 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Theravance Biopharma, Inc.'s current P/E ratio?
- Theravance Biopharma, Inc. (TBPH) has a trailing P/E ratio of 16.42 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Theravance Biopharma, Inc.'s market capitalisation?
- Theravance Biopharma, Inc.'s market cap is $886.77M based on our latest snapshot. See how it ranks by market cap →
- What is TBPH's 52-week range?
- Over the past 52 weeks, TBPH has traded between $13.08 and $21.03. What does the 52-week range mean? →
- How volatile is Theravance Biopharma, Inc. compared to the market?
- Theravance Biopharma, Inc. has a beta of 0.24, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Theravance Biopharma, Inc. pay a dividend?
- Theravance Biopharma, Inc. does not currently pay a dividend according to our latest data.
- What exchange is TBPH listed on?
- TBPH is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Theravance Biopharma, Inc. in?
- Theravance Biopharma, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →